22
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Investigations of New N1-Substituted Pyrazoles as Anti-Inflammatory and Analgesic Agents having COX Inhibitory Activity

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 349-368 | Received 17 Oct 2023, Accepted 20 Dec 2023, Published online: 30 Jan 2024

References

  • Ashour HMA , El-Ashmawy IM , Bayad AE . Synthesis and pharmacological evaluation of new pyrazolyl benzenesulfonamides linked to polysubstituted pyrazoles and thiazolidinones as anti-inflammatory and analgesic agents. Monatsh. Chem. 147(3), 605–618 (2016).
  • Bekhit AA , Farghaly AM , Shafik RM et al. Synthesis, biological evaluation and molecular modeling of novel thienopyrimidinone and triazolothienopyrimidinone derivatives as dual anti-inflammatory antimicrobial agents. Bioorg. Chem. 77, 38–46 (2018).
  • Hassanein HH , Georgey HH , Fouad MA , Kerdawy AME , Said MF . Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors. Future Med. Chem. 9(6), 553–578 (2017).
  • Riemann A , Ihling A , Reime S , Gekle M , Thews O . Impact of the tumor microenvironment on the expression of inflammatory mediators in cancer cells. Adv. Exp. Med. Biol. 923, 105–111 (2016).
  • Kaur P , Arora V , Kharb R . Pyrazole as an anti-inflammatory scaffold: a comprehensive review. Int. J. Health Sci. 6(Suppl. 2), 8281–8289 (2022).
  • Zeilhofer HU . Prostanoids in nociception and pain. Biochem. Pharmacol. 73, 165–174 (2007).
  • Labib MB , Fayez AM , El-Nahass E-S , Awadallah M , Halim PA . Novel tetrazole-based selective COX-2 inhibitors: design, synthesis, anti-inflammatory activity, evaluation of PGE2, TNF-α, IL-6 and histopathological study. Bioorg. Chem. 104, 104308 (2020).
  • Ragab FA , Gawad NMA , Georgey HH , Said MF . Synthesis of novel 1,3,4-trisubstituted pyrazoles as anti-inflammatory and analgesic agents. Eur. J. Med. Chem. 63, 645–654 (2013).
  • Mason RP , Walter MF , Day CA , Jacob RF . A biological rationale for the cardiotoxic effects of rofecoxib: comparative analysis with other COX-2 selective agents and NSAIDs. Subcell. Biochem. 42, 175–190 (2007).
  • Stillman MJ , Stillman MT . Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly. A clinical use pathway. Geriatrics 62(2), 26–34 (2007).
  • Bishop-Bailey D , Mitchell JA , Warner TD . COX-2 in cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 26(5), 956–958 (2006).
  • Dannhardt G , Laufer S . Structural approaches to explain the selectivity of COX-2 inhibitors: is there a common pharmacophore? Curr. Med. Chem. 7(12), 1101–1112 (2000).
  • van Ryn J , Trummlitz G , Pairet M . COX-2 selectivity and inflammatory processes. Curr. Med. Chem. 7(11), 1145–1161 (2000).
  • Mantzanidou M , Pontiki E , Hadjipavlou-Litina D . Pyrazoles and pyrazolines as anti-inflammatory agents. Molecules 26, 3439 (2021).
  • Gedawy EM , Kassab AE , Kerdawy AME . Design, synthesis and biological evaluation of novel pyrazole sulfonamide derivatives as dual COX-2/5-LOX inhibitors. Eur. J. Med. Chem. 189, 112066 (2020).
  • Smith WL , Dewitt DL , Garavito RM . Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Bioch. 69, 145–182 (2000).
  • Kiefer JR , Pawlitz JL , Moreland KT et al. Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature 405, 97–101 (2000).
  • Kurumbail RG , Stevens AM , Gierse JK et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384, 644–648 (1996).
  • Wang JL , Limburg D , Graneto MJ et al. The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life. Bioorg. Med. Chem. Lett. 20(23), 7159–7163 (2010).
  • Li J , Hao Q , Cao W , Vadgama JV , Wu Y . Celecoxib in breast cancer prevention and therapy. Cancer Manag. Res. 10, 4653–4667 (2018).
  • Faisal M , Saeed A , Hussain S , Dar P , Larik FA . Recent developments in synthetic chemistry and biological activities of pyrazole derivatives. J. Chem. Sci. 131, 70 (2019).
  • Ragab FA , Abdel-Gawad NM , Georgey HH , Said MF . Pyrazolone derivatives: synthesis, anti-inflammatory, analgesic, quantitative structure–activity relationship and in vitro studies. Chem. Pharm. Bull. 61(8), 834–845 (2013).
  • Li Z , Wang Z-C , Li X et al. Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents. Eur. J. Med. Chem. 169, 168–184 (2019).
  • Pattanashetty SH , Hosamani KM , Shettar AK , Shafeeullac RM . Design, synthesis and computational studies of novel carbazole N-phenylacetamide hybrids as potent antibacterial, anti-inflammatory, and antioxidant agents. J. Heterocyclic Chem. 55, 1765 (2018).
  • Lipinski CA , Lombardo F , Dominy BW , Feeney PJ . Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3–26 (2001).
  • Cheng K-M , Wu JB , Lin H-C et al. Dibromination of 5-pyrazolones and 5-hydroxypyrazoles via dibromoisocyanuric acid. J. Heterocyclic Chem. 47, 1153 (2010).
  • Kumar R , Kaur M , Bahia MS , Silakari O . Synthesis, cytotoxic study and docking based multidrug resistance modulator potential analysis of 2-(9-oxoacridin-10(9H)-yl)-N-phenyl acetamides. Eur. J. Med. Chem. 80, 83–91 (2014).
  • Monforte A-M , Ferro S , Luca LD et al. Design and synthesis of N1-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. 22, 1459–1467 (2014).
  • Castagnolo D , Logu AD , Radi M et al. Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis . Bioorg. Med. Chem. 16(18), 8587–8591 (2008).
  • Khalil AK , Hassan MA , Mohamed MM , El-Sayed AM . Phase-transfer catalyzed alkylation and cycloalkylation of 3-substituted-1H-pyrazol-2-in-5-ones in the absence or presence of carbon disulphide. Phosphorus Sulfur Silicon Relat. Elem. 180, 479–496 (2005).
  • Winter CA , Risely EA , Nuss GM . Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 111, 544–547 (1962).
  • Naumov RN , Panda SS , Girgis AS , George RF , Farhat M , Katritzky AR . Synthesis and QSAR study of novel anti-inflammatory active mesalazine-metronidazole conjugates. Bioorg. Med. Chem. Lett. 25(11), 2314–2320 (2015).
  • Panda SS , Girgis AS , Honkanadavar HH , George RF , Srour AM . Synthesis of new ibuprofen hybrid conjugates as potential anti-inflammatory and analgesic agents. Future Med. Chem. 12, 1369–1386 (2020).
  • Collirer HJ , Dinneen LC , Johnson CA , Scheider C . The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br. J. Pharmac. Chemother. 32, 295–310 (1968).
  • Finney DJ . Statistical Methods in Biological Assay. (2nd ed). Griffin, London, UK (1964).
  • Robert A , Nezamis JE , Phillips JP . Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat. Gastroenterology 55, 481–487 (1968).
  • Bancroft JD , Stevans A , Turner DR . Theory and practice of histological techniques. (4th Ed.) Churchill Livingstone, Edinburgh (1996).
  • Boligon AA , Freitas RBD , Brum TFD et al. Antiulcerogenic activity of Scutia buxifolia on gastric ulcers induced by ethanol in rats. Acta Pharm. Sin. B 4(5), 358–367 (2014).
  • Guo R , Wu K , Chen J et al. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells. Cell Physiol. Biochem. 32(6), 1668–1680 (2013).
  • Heilman JM , Burke TJ , McClain CJ , Watson WH . Transactivation of gene expression by NFκB is dependent on thioredoxin reductase activity. Free Radic. Biol. Med. 51(8), 1533–1542 (2011).
  • Xu S , Hermanson DJ , Banerjee S et al. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding network. J. Biol. Chem. 289(10), 6799–6808 (2014).
  • Berman HM , Westbrook J , Feng Z et al. The Protein Data Bank. Nucleic Acids Res. 28(1), 235–242 (2000).
  • Morris GM , Huey R , Lindstrom W et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30(16), 2785–2791 (2009).
  • Abraham MJ , Murtola T , Schulz R et al. GROMACS: high-performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1–2, 19–25 (2015).
  • Hornak V , Abel R , Okur A , Strockbine B , Roitberg A , Simmerling C . Comparison of multiple amber force fields and development of improved protein backbone parameters. Proteins 65(3), 712–725 (2006).
  • Sousa da Silva AW , Vranken WF . ACPYPE–AnteChamber PYthon Parser interfacE. BMC Res. Notes 5, 367 (2012).
  • Cerutti DS , Duke RE , Darden TA , Lybrand TP . Staggered mesh Ewald: an extension of the smooth particle-mesh Ewald method adding great versatility. J. Chem. Theory Comput. 5(9), 2322–2338 (2009).
  • Hess B . P-LINCS: a parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput. 4(1), 116–122 (2008).
  • Humphrey W , Dalke KS . VMD: visual molecular dynamics. J. Mol. Graph. 14(1), 33–38 (1996).
  • Turner PJ . XMGRACE, Version 5.1. 19. Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology, Beaverton, OR, USA (2005).
  • Molinspiration Cheminformatics. www.molinspiration.com/services/properties.html (Accessed 24 March 2014 ).
  • Oeckinghaus A , Ghosh S . The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1(4), a000034 (2009).
  • Meade EA , Smith WL , Dewitt DL . Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268(9), 6610–6614 (1993).
  • Garavito RM , Dewitt DL . The cyclooxygenase isoforms: structural insights into the conversion of arachidonic acid to prostaglandins. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1441(2–3), 278–287 (1999).
  • Hassan GS , Rahman DEA , Abdelmajeed EA , Refaey RH , Salem MA , Nissan YM . New pyrazole derivatives: synthesis, anti-inflammatory activity, cycloxygenase inhibition assay and evaluation of mPGES. Eur. J. Med. Chem. 171, 332–342 (2019).
  • Soliva R , Almansa C , Kalko SG , Luque FJ , Orozco M . Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site? J. Med. Chem. 46(8), 1372–1382 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.